くすりのしおり

Internal
Revised: 1/2019

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
VIMPAT TABLETS 50mg
 Active ingredient:
Lacosamide
 Dosage form:
pink tablet, major axis: approximately 10.4 mm, minor axis: approximately 4.9 mm, thickness: approximately 3.2 mm
 Print on wrapping:
(face)ビムパット 50mg SP50, (back)Vimpat 50mg, ビムパット 50mg

Effects of this medicine

This medicine calms excessive nerve excitement in the brain and suppresses epileptic seizures.
It is usually used to treat partial seizures.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have liver disorder.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • For adults: In general, start with taking 50 mg of the active ingredient at a time, twice a day and continue to take for more than a week. Then the dose will be increased gradually to take 100 mg twice a day as a maintenance dose. The dosage may be adjusted according to the age and symptoms, however, if the dosage needs to be increased, the daily dose will be increased by 100 mg or less at an interval of more than a week. The maximum daily dose is 400 mg.
    For children: In general, for children from 4 years of age, start with taking 2 mg of the active ingredient per kilogram of the body weight a day (2 mg/kg/day) in 2 divided doses, and continue to take for more than a week. Then the dose will be increased gradually by 2 mg/kg/day at an interval of at least 1 week, to 6 mg/kg/day for children weighing less than 30 kg and 4 mg/kg/day for children weighing from 30 kg to under 50 kg as a maintenance dose in 2 divided doses. However, the maintenance dose can be further increased by 2 mg/kg/day or less at an interval of more than a week according to the symptoms. The maximum dose is 12 mg/kg/day for children weighing less than 30 kg and 8 mg/kg/day for children weighing from 30 kg to under 50 kg. The dosage in children 50 kg or greater is the same as in adults.
    This preparation contains 50 mg of the active ingredient in a tablet. In any case, strictly follow the instructions.
  • If you miss a dose, take the missed dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. You should never take two doses at one time.
  • If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
  • Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine

  • This medicine may cause dizziness, foggy vision, sleepiness, and decrease in attention/concentration/reflex action. Do not perform dangerous operations such as driving a car.
  • If you are a patient with cardiac disorder or taking bradycrotic medicine, electrocardiogram examination may be performed during taking this medicine. Keep all laboratory test schedules.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include dizziness, fatigue, somnolence, headache, vomiting and nausea, tremor, double vision and foggy vision. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • abnormal pulse, shortness of breath, loss of consciousness [atrioventricular block, bradycardia, syncope]
  • fever, erythema, blister/erosion [toxic epidermal necrolysis, mucocutaneous-ocular syndrome]
  • rash, fever, enlarged lymph nodes [drug-induced hypersensitivity syndrome]
  • sore throat, headache, muscle pain [agranulocytosis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
  • Discard the remainder. Do not store them. Ask the pharmacist and the medical institution how to discard them.

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z